about
Early detection of prostate cancer relapse by biochemistry and diagnostic imagingMultimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospect¹⁸F-fluoromethylcholine or ¹⁸F-fluoroethylcholine pet for prostate cancer imaging: which is better? A literature revision.Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis.Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil.Global minimally invasive pyeloplasty study in children: Results from the Pediatric Urology Expert Group of the European Association of Urology Young Academic Urologists working party.Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution.Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.Should radical prostatectomy be encouraged at any age? A critical non-systematic review.Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse.The future of choline pet in the era of PMSA.Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma.Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg?Mid-term Outcomes Following Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Status Post-radical Prostatectomy.Risk stratification for benign prostatic hyperplasia.Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer.Posterior muscolofascial reconstruction incorporated into urethrovescical anastomosis during robot-assisted radical prostatectomy.Can (68)GA-PSMA or radiolabeled choline PET/CT guide salvage lymph node dissection in recurrent prostate cancer?Income inequality and treatment of African American men with high-risk prostate cancer.18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study.Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term FollowupComparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomyProstate cancer: more effective use of underutilized postoperative radiation therapy68Ga-dotatoc vs. 18F-FDG vs. radiolabelled PSMA PET/CT in renal cancer patientsEAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)Ultrasound-guided transversus abdominis plane block (US-TAPb) for robot-assisted radical prostatectomy: a novel '4-point' technique-results of a prospective, randomized studyTHE WAR IS OPENED: PSMA VS. 64CuCL2 VS. CHOLINE PET/CTIs 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage LymphadenectomyIs there any benefit in adding postoperative adjuvant concurrent radiotherapy and chemotherapy for penile cancer with regional lymph node metastasis?Is "extreme" bladder neck preservation in robot-assisted radical prostatectomy a safe procedure?Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomyTechnical innovations to optimize continence recovery after robotic assisted radical prostatectomyMinimally invasive urologic surgery is safe during COVID-19: experience from two high-volume centers in Italy
P50
Q26799445-7F660059-79DC-4861-93A5-78F4D308DEAEQ37528968-8DE77C12-9785-404C-BB8E-D5E9FA3EA834Q38331316-5433ED24-A10B-4682-8139-EEBD382CAA8DQ38708189-EAC8D921-191E-4A60-95CC-5130487610B0Q38934646-CC875332-7F54-4C50-B2A7-EB01585E9066Q39487668-6F13F8BC-9D51-4024-AAF4-39FD19419095Q39653865-3FBD17BD-3282-4CBF-8AD2-9113127F71C3Q41086250-8F27901A-EF9E-4759-A910-A3E849DB40BCQ41720279-FD1CDA6F-B4E9-41FA-BA76-FFB5177B96CEQ43768745-89B9C5D3-6C06-4FD9-B318-44DD55B3064EQ47207206-0663B539-E23B-4764-9FA5-1E38E46F2E81Q47318581-6ADB9336-5165-4F13-82F3-69D214347EB6Q47564539-7724F560-9A33-4F84-A439-7BFC34DFA645Q47703022-6D679A34-6EA1-44C9-AD5D-D3792A16AC7CQ48095608-A860C63B-AE71-4E1B-9E28-C874E39E1212Q50126305-B269818C-F184-447B-9543-C1948B7262FEQ50525698-26CC9ABA-2980-432A-A5EF-5B5D78243398Q50791341-C9E85A2B-BCBF-47C1-B0DC-9427F6291578Q50852889-20D4AC7F-9A14-4620-8C04-B175A8FCC315Q51298885-A104C048-14A9-41ED-B7ED-163F08892946Q52983462-7AE87CEF-A184-479F-9074-DC61F628F812Q53813550-640A6E11-95B7-47CD-869C-CADDD07D7961Q64933841-00A9B46F-B80C-4296-9342-36D1F2C59104Q87002662-E43A9F06-E056-496E-A468-670BA0E9B620Q87071909-2A541C3D-F5CE-4D82-B9BD-DCE8F312C945Q90389831-2195A93E-05FD-44B2-9FBF-6B3C8D9BB247Q90428718-C43321CE-2DCE-41EB-9518-E9187F057F39Q90527656-0DCE1513-749D-4315-BDD6-18A8329DF7DBQ90593954-152350B0-9BD6-4CA9-BC95-00512C4EF950Q90987227-81E6E796-1F54-4C44-9CC5-27A405BEDD92Q91390936-76E33B3E-C631-4EB6-953D-24E47575BE09Q92234427-8A065B33-CD7F-4DDA-BE45-C900860951DEQ92818971-E7A29B76-E3C4-40A2-9F27-F1D42184B095Q92918527-6D309F47-7873-43D1-8E61-87586F4BBE25Q92918530-4AC91BEA-2237-4691-9964-A165009735ACQ96433027-365DF728-6210-4302-87ED-2952D46CF9F2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabio Zattoni
@ast
Fabio Zattoni
@bar
Fabio Zattoni
@de
Fabio Zattoni
@en
Fabio Zattoni
@es
Fabio Zattoni
@fr
Fabio Zattoni
@nl
Fabio Zattoni
@sl
type
label
Fabio Zattoni
@ast
Fabio Zattoni
@bar
Fabio Zattoni
@de
Fabio Zattoni
@en
Fabio Zattoni
@es
Fabio Zattoni
@fr
Fabio Zattoni
@nl
Fabio Zattoni
@sl
altLabel
Fabio Zattoni M.D.
@en
prefLabel
Fabio Zattoni
@ast
Fabio Zattoni
@bar
Fabio Zattoni
@de
Fabio Zattoni
@en
Fabio Zattoni
@es
Fabio Zattoni
@fr
Fabio Zattoni
@nl
Fabio Zattoni
@sl
P106
P1153
54888963200
P21
P31
P3835
fabio-zattoni
P496
0000-0002-4178-373X